Assignee
ALLAKOS INC
US·7 granted patents·17 pending applications·25 citations·filing 2014–2023
Top patents by PatentIndex Score
24 records- 0189US10604577B2Methods and compositions for treating systemic mastocytosisALLAKOS INC·Filed 2016·Granted Mar 31, 2020·5 cites·10 claims
- 0289US9546215B2Anti-Siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2014·Granted Jan 17, 2017·7 cites·68 claims
- 0383US11203638B2Methods and compositions for treating perennial allergic conjunctivitis and keratoconjunctivitisALLAKOS INC·Filed 2018·Granted Dec 21, 2021·2 cites·23 claims
- 0483US10774145B2Methods and compositions for treating fibrotic diseasesALLAKOS INC·Filed 2016·Granted Sep 15, 2020·3 cites·37 claims
- 0583US10183996B2Methods and compositions for treating Siglec-8 associated diseasesALLAKOS INC·Filed 2015·Granted Jan 22, 2019·6 cites·58 claims
- 0676US11773162B2Anti-Siglec-7 antibodies for the treatment of cancerALLAKOS INC·Filed 2017·Granted Oct 3, 2023·2 cites·14 claims
- 0773US2023331854A1Methods and compositions for treating systemic mastocytosisALLAKOS INC·Filed 2022·Application pending·0 cites
- 0872US2022331412A1Anti-siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2022·Application pending·0 cites
- 0971US2023303686A1Methods and compositions for treating fibrotic diseasesALLAKOS INC·Filed 2022·Application pending·0 cites
- 1064US2020054723A1Anti-siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2019·Application pending·0 cites
- 1162US2022162307A1Methods and compositions for treating allergic ocular diseasesALLAKOS INC·Filed 2021·Application pending·0 cites
- 1261US2024084005A1Anti-siglec-6 antibodies and methods of use thereofALLAKOS INC·Filed 2023·Application pending·0 cites
- 1361US2021107977A1Methods and compositions for treating fibrotic diseasesALLAKOS INC·Filed 2020·Application pending·0 cites
- 1461US2020181270A1Methods and compositions for treating systemic mastocytosisALLAKOS INC·Filed 2020·Application pending·0 cites
- 1558US2024158498A1Anti-siglec-8 antibody formulationsALLAKOS INC·Filed 2022·Application pending·0 cites
- 1657US2023406920A1Anti-siglec-8 antibody formulationsALLAKOS INC·Filed 2021·Application pending·0 cites
- 1757US2017209556A1Anti-siglec-8 antibodies and methods of use thereofALLAKOS INC·Filed 2016·Application pending·0 cites
- 1850US2022380460A1Methods and compositions for treating irritable bowel syndrome and functional dyspepsiaALLAKOS INC·Filed 2020·Application pending·0 cites
- 1949US11912766B2Anti-Siglec-7 antibodies having reduced effector functionALLAKOS INC·Filed 2019·Granted Feb 27, 2024·0 cites·11 claims
- 2049US2022257758A1Methods of administering anti-siglec-8 antibodies and corticosteroidsALLAKOS INC·Filed 2020·Application pending·0 cites
- 2145US2020270344A1Methods and compositions for treating inflammatory gastrointestinal disordersALLAKOS INC·Filed 2018·Application pending·0 cites
- 2244US2022135673A1Methods and compositions for treating mast cell gastritis, mast cell esophagitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritisALLAKOS INC·Filed 2020·Application pending·0 cites
- 2343US2021246205A1Methods and compositions for treating chronic urticariaALLAKOS INC·Filed 2019·Application pending·0 cites
- 2438US2019338027A1Methods and compositions for treating chronic obstructive pulmonary disorderALLAKOS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →